Researchers at National Taiwan University have developed a modular platform to reprogram tumour-derived extracellular vesicles (EVs), transforming them from oncogenic messengers into safe, ...

Bacteria are ubiquitous microscopic organisms capable of rapid growth. While beneficial strains like lactic acid bacteria (LAB) promote gut health and food preservation, pathogenic bacteria such as ...

New research from scientists at the Karolinska Institutet in Sweden and their collaborators elsewhere describes a way of improving extracellular vesicles’ ability to transport things like therapeutic ...

A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has developed a new class of engineered extracellular vesicles (EVs) capable of ...

This review article, published in LabMed Discovery by Prasanna Ganesan and Rengarajan Murugesan, explores the role of engineered vesicles—specifically extracellular vesicles (EVs) and synthetic ...

Announcing a new article publication for BIO Integration journal. Extracellular vesicles (EVs) are membrane-bound nanoparticles secreted by cells and have emerged as promising therapeutic agents for ...

Extracellular vesicles (EVs) could serve as outstanding drug delivery vehicles. Their low toxicity and low immunogenicity would make them useful in sustained treatment or redosing scenarios. But there ...

Nanovesicles can be bioengineered to target cancer cells and deliver treatments directly, according to new research. Nanovesicles can be bioengineered to target cancer cells and deliver treatments ...

Ischemic stroke remains a leading global cause of disability and mortality, and a major challenge in stroke treatment is "reperfusion injury"—where return of blood flow causes oxidative stress and ...